How has been the historical performance of Cohance Life?
Cohance Life's historical performance shows fluctuating net sales, with a decrease from 1,340.33 Cr in March 2023 to 1,197.58 Cr in March 2025, alongside declining profits and increased total assets and liabilities. Operating profit margin fell to 31.33%, reflecting overall volatility in financial metrics.
Answer:The historical performance of Cohance Life shows a fluctuating trend in key financial metrics over the years.Breakdown:
Cohance Life's net sales reached 1,197.58 Cr in March 2025, an increase from 1,051.35 Cr in March 2024, but a decline from 1,340.33 Cr in March 2023. The total operating income mirrored this trend, standing at 1,197.58 Cr in March 2025, while total expenditure (excluding depreciation) rose to 822.38 Cr from 645.54 Cr in March 2024. Operating profit (PBDIT) decreased to 433.76 Cr in March 2025 from 467.72 Cr in the previous year, reflecting a decline in operating profit margin to 31.33%. Profit before tax also fell to 343.92 Cr in March 2025, down from 405.67 Cr in March 2024, leading to a profit after tax of 264.77 Cr. The net profit for March 2025 was 267.87 Cr, a decrease from 300.28 Cr in March 2024. The company's total assets increased to 2,254.09 Cr in March 2024 from 1,965.74 Cr in March 2023, while total liabilities also rose to 2,254.09 Cr, indicating a growing financial base. Cash flow from operating activities was 358.00 Cr in March 2024, down from 457.00 Cr in March 2023, contributing to a net cash outflow of 17.00 Cr in March 2024. Overall, Cohance Life's financial performance reflects volatility in sales and profits, alongside a significant increase in total assets and liabilities.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
